Larkberget AB OMXSTO:LARK:
LÄRKBERGET INVESTS 50 MSEK IN NAXS AB
Larkberget Invests SEK 50 Mln In Naxs AB
Earlier from Larkberget
- LARK: Strategic shift to investment focus completed; strong cash, first investments imminent
- LARK: CombiGene halts R&D, posts SEK 44.9m loss, and shifts focus to investments or dividends
- LARK: Strategic Partner A/S proposes a new board led by Luca Di Stefano for CombiGene
- LARK: Gene therapy focus sharpened, COZY prioritized, and cost cuts extend liquidity to 2026
- LARK: CG01 rights regained, CGT2 discontinued, COZY advanced; sales and cash declined year-over-year
Later from Larkberget
- Nasdaq Stockholm Removes Larkberget's Observation Status
- Lärkberget Net Asset Value Per Share As Of Jan 15, 2025 Is SEK 3.08
- Larkberget Appoints Luca Di Stefano As CEO
- Lärkberget Reports H2 Revenue Loss Of SEK 252,000
- Larkberget Net Asset Value Per Share At SEK 3.04
Follow Larkberget into a list and get an email when it puts out news.
Follow Larkberget